Method for preparing miltoquinone through oxidation
By using cheap metal ion oxidizers to prepare mitotone salts at room temperature, the hazards and toxicity problems in the existing oxidation process are solved, and efficient and environmentally friendly mitotone production is achieved, which is suitable for large-scale industrial applications.
Patent Information
- Application Number
- CN202411093285.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-09
AI Technical Summary
The existing oxidation process of mitoquinone is dangerous to use air or oxygen, and the oxidation time is long, and other oxidants used, such as potassium permanganate and potassium dichromate, are toxic and corrosive, which are harmful to the environment.
Mitoquinone salt is prepared at room temperature by using cheap and easy-to-get metal ion oxidants, such as ferric chloride, iron sulfate, copper chloride, etc., through the reaction of the salt of intermediate A and the metal ion oxidant, the mitotone salt is prepared at room temperature, and recrystallization and chemistry are used. Purification processes such as precipitation and column chromatography avoid the use of dangerous and toxic reagents.
It effectively reduces the oxidation cost and reduces the generation of industrial waste. It has simple process and convenient operation. It is suitable for large-scale industrial production. It has cheap and easy-to-get raw materials and high yields.
Smart Images

Figure CN118994239A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic synthesis, and in particular to a method for preparing mitoquinone by oxidation. Background Art
[0002] Mitochondria are the main target organs for the production and attack of reactive oxygen species in the body. The loss of mitochondrial structure and function induced by ROS imbalance is associated with a variety of age-related diseases. ROS imbalance in mitochondria leads to mitochondrial lipid and protein oxidation, mitochondrial RNA / DNA damage, Ca 2+ It depends on the activation of permeability transition pore protein, the release of cytochrome C, etc., to induce the formation of apoptotic bodies, and further promote cell apoptosis, ultimately leading to irreversible organic damage of the organism (or organelle). Mitoquinone is a mitochondrial targeted antioxidant based on TPP, which can block H 2 O 2 Mitoquinone can induce intracellular ROS reaction and prevent oxidative damage. Currently, Mitoquinone has been widely used in anti-aging, anti-tumor and treatment of neurodegenerative diseases.
[0003] Mitoquinone is composed of triphenylphosphonium cation and quinone group with antioxidant effect covalently bonded by a fatty chain, usually existing in the form of Mitoquinone salt. Its structural formula is shown below:
[0004]
[0005] The existing synthesis method of mitoquinone generally first synthesizes idebenone or directly uses idebenone as a raw material, then constructs OMs or obtains the corresponding bromide through Appel reaction, further reduces quinone to phenol, and then reacts with triphenylphosphine to obtain the corresponding salt, and finally obtains mitoquinone mesylate or mitoquinone bromide through oxidation. The current oxidation process uses air or oxygen for oxidation, and the oxidation time is too long, and oxygen is flammable and explosive, which has certain dangers. If other oxidants are used, such as potassium permanganate, potassium dichromate, periodic acid, etc., they are highly toxic, corrosive, and have great harm to the environment. Therefore, it is necessary to propose a new oxidation method to solve some problems existing in the above process. Summary of the invention
[0006] The technical problem to be solved by the present invention is to provide a method for preparing mitoquinone by oxidation in view of the deficiencies in the above-mentioned prior art.
[0007] In order to solve the above technical problems, the technical solution adopted by the present invention is: a method for preparing mitoquinone by oxidation, comprising the following steps:
[0008] S1. The salt of intermediate A is dissolved in an organic solvent, a metal ion oxidant is added, and the mixture is stirred to react to obtain a crude product of mitroquinone salt;
[0009] S2, purifying the crude product to obtain mitoquinone salt;
[0010] Among them, the structural formula of intermediate A is shown as follows:
[0011]
[0012] Preferably, the metal ion oxidant is one or more of ferric chloride, ferric sulfate, cupric chloride and cupric bromide.
[0013] Preferably, the salt of intermediate A is a mesylate salt of intermediate A or a bromide salt of intermediate A;
[0014] The mesylate of intermediate A is prepared by using idebenone as a raw material, constructing OMs, reducing, and then forming a salt with triphenylphosphine. The bromide of intermediate A is prepared by using idebenone as a raw material, constructing OMs, brominating, reducing, and then forming a salt with triphenylphosphine.
[0015] Preferably, the molar ratio of the salt of intermediate A to the metal ion oxidant is 1:0.01 to 0.20.
[0016] Preferably, the organic solvent is one or more of ethanol, methanol, and dichloromethane;
[0017] The volume of the organic solvent is 5 to 20 times the weight of the salt of the intermediate A, wherein the unit of volume is mL and the unit of weight is g.
[0018] Preferably, the reaction time in step S1 may be 0.5-12 h, and the reaction temperature is room temperature.
[0019] Preferably, the purification process in step S2 is a combination of one or more of recrystallization, chemical precipitation, and column chromatography.
[0020] Preferably, step S2 specifically comprises:
[0021] S2-1, adding the crude product of mitoquinone salt to the recrystallization solvent, stirring at 30-120°C for 1-4h, and then cooling to 25°C;
[0022] S2-2, discard the supernatant, add the product into the recrystallization solvent, stir at 30-120°C for 1-4h, then cool to 25°C, and then concentrate under reduced pressure at 40°C to obtain mitroquinone salt.
[0023] Preferably, the recrystallization solvent is one or more of ethyl acetate, toluene, n-hexane, and ether, and the volume of the recrystallization solvent is 1 to 10 times the weight of the crude mitroquinone, wherein the unit of volume is mL and the unit of weight is g.
[0024] Preferably, step S2 specifically comprises: adding the crude product of mitoquinone salt to diethylaminetetraacetic acid, stirring at room temperature for 1-4 hours, filtering with suction, rinsing the filter cake with ethanol, and concentrating the filtrate under reduced pressure at 40° C. to obtain mitoquinone salt.
[0025] Preferably, step S2 specifically comprises: purifying the crude product of mitoquinone salt by column purification with 200-300 mesh silica gel, eluting with a mixed solution of dichloromethane:methanol in a volume ratio of 50:1, and concentrating the obtained eluate under reduced pressure at 40° C. to obtain mitoquinone salt.
[0026] The beneficial effects of the present invention are:
[0027] The invention provides a method for preparing mitoquinone by oxidation. The invention uses cheap and readily available metal ions as oxidants to oxidize the mesylate or bromide salt of an intermediate A at room temperature to obtain mitoquinone. The method provided by the invention effectively reduces oxidation costs, avoids the use of dangerous and toxic reagents, effectively reduces the generation of three industrial wastes, and has a simple process, convenient operation, cheap and readily available raw materials, high yield, and is conducive to large-scale industrial production. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 This is the synthetic route of intermediate A mesylate;
[0029] Figure 2 is the H NMR spectrum of the mesylate salt of intermediate A;
[0030] Figure 3 This is the synthetic route of the intermediate A bromide salt;
[0031] Figure 4 is the H NMR spectrum of the bromide salt of intermediate A;
[0032] Figure 5 HPLC spectrum of the mitoquinone salt product obtained in Example 3;
[0033] Figure 6 The following is the hydrogen nuclear magnetic resonance spectrum of the mitoquinone salt product obtained in Example 3. DETAILED DESCRIPTION
[0034] The present invention is further described in detail below in conjunction with embodiments so that those skilled in the art can implement the invention with reference to the description.
[0035] It should be understood that the terms such as “having”, “including” and “comprising” used herein do not exclude the existence or addition of one or more other elements or combinations thereof.
[0036] The test methods used in the following examples are conventional methods unless otherwise specified. The materials and reagents used in the following examples are all commercially available unless otherwise specified. In the following examples, if no specific conditions are specified, the experiments were carried out under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used, if the manufacturer is not specified, are all conventional products that can be purchased commercially.
[0037] The present invention provides a method for preparing mitoquinone by oxidation, comprising the following steps:
[0038] S1. The salt of intermediate A is dissolved in an organic solvent, a metal ion oxidant is added, and the mixture is stirred to react to obtain a crude product of mitroquinone salt;
[0039] S2, purifying the crude product to obtain mitoquinone salt;
[0040] Among them, the structural formula of intermediate A is shown as follows:
[0041]
[0042] The reaction route is as follows:
[0043]
[0044] In a preferred embodiment, the metal ion oxidant is one or more of ferric chloride, ferric sulfate, cupric chloride, and cupric bromide.
[0045] In a preferred embodiment, the salt of intermediate A is a mesylate salt of intermediate A or a bromide salt of intermediate A;
[0046] Among them, the mesylate of intermediate A is prepared by using idebenone as a raw material, constructing OMs, reducing, and then forming a salt with triphenylphosphine. The bromide of intermediate A is prepared by using idebenone as a raw material, constructing OMs, brominating, reducing, and then forming a salt with triphenylphosphine.
[0047] In a preferred embodiment, the molar ratio of the salt of intermediate A to the metal ion oxidant is 1:0.01 to 0.20. For example, it can be 1:0.01, 1:0.05, 1:0.10, 1:0.20 or any value between them, and the most preferred ratio is 1:0.05;
[0048] In a preferred embodiment, the organic solvent is one or more of ethanol, methanol, and dichloromethane; ethanol is most preferred.
[0049] The volume of the organic solvent is 5 to 20 times the weight of the salt of the intermediate A, wherein the unit of volume is mL and the unit of weight is g. For example, it can be 5, 10, 15, 20 times or any value in between, and most preferably 15 times.
[0050] In a preferred embodiment, the reaction time in step S1 can be 0.5-12 hours, and the reaction temperature is room temperature, for example, 0.5, 2, 5, 8 hours or any value between any two of them, and most preferably 5 hours.
[0051] In a preferred embodiment, the purification process in step S2 is a combination of one or more of recrystallization, chemical precipitation, and column chromatography, and recrystallization is most preferred.
[0052] In a preferred embodiment, step S2 is specifically as follows:
[0053] S2-1, adding the crude product of mitoquinone salt to the recrystallization solvent, stirring at 30-120°C for 1-4h, and then cooling to 25°C;
[0054] S2-2, discard the supernatant, add the product into the recrystallization solvent, stir at 30-120°C for 1-4h, then cool to 25°C, and then concentrate under reduced pressure at 40°C to obtain mitroquinone salt.
[0055] In a preferred embodiment, the recrystallization solvent is one or more of ethyl acetate, toluene, n-hexane, and ether, and most preferably ethyl acetate.
[0056] In a preferred embodiment, the volume of the recrystallization solvent is 1 to 10 times the weight of the crude product of mitroquinone, wherein the unit of volume is mL and the unit of weight is g. For example, it can be 1, 3, 7, 10 times or any value between them, and most preferably 3 times. The recrystallization temperature is 30 to 120°C, for example, it can be 30°C, 50°C, 80°C, 100°C, and most preferably 70°C.
[0057] In a preferred embodiment, step S2 specifically comprises: adding the crude product of mitoquinone salt to diethylaminetetraacetic acid, stirring at room temperature for 1-4 hours, filtering with suction, rinsing the filter cake with ethanol, and concentrating the filtrate under reduced pressure at 40° C. to obtain mitoquinone salt.
[0058] In a preferred embodiment, step S2 specifically comprises: purifying the crude product of mitoquinone salt by column chromatography with 200-300 mesh silica gel, eluting with a mixed solution of dichloromethane:methanol in a volume ratio of 50:1, and concentrating the obtained eluate under reduced pressure at 40° C. to obtain mitoquinone salt.
[0059] The above is the overall concept of the present invention, and detailed embodiments and comparative examples are provided below on the basis of the overall concept of the present invention to further illustrate the present invention.
[0060] In the following examples, the preparation methods of the mesylate salt of intermediate A and the bromide salt of intermediate A are as follows.
[0061] 1. Methanesulfonate of intermediate A
[0062] The mesylate of intermediate A (abbreviated as intermediate A mesylate) is prepared from idebenone as a raw material, by constructing OMs, reducing, and then salifying with triphenylphosphine; the synthetic route is as follows: Figure 1 As shown, the specific synthesis method is:
[0063] Add idebenone (200g, 0.59mol), dichloromethane (3L, 15V), triethylamine (173ml, 1.24mol) to a 5L three-necked flask, cool to below 5°C in an ice-water bath, and slowly drop methyl yellow chloride (91ml, 1.18mol). After the dropwise addition, warm to room temperature and stir for 1h. Add 500ml 1N hydrochloric acid to the reaction solution and stir for 20min. Separate the liquid, extract the organic phase with 500ml water once, separate the liquid again, dry the organic phase with anhydrous sodium sulfate and concentrate under reduced pressure. Obtain 240g of a reddish brown oil with a yield of 99.53%.
[0064] Add the above-obtained reddish brown oil (240g, 0.59mol) and methanol (3.6L) into a 10L three-necked flask, place in an ice-water bath and cool to about 5°C under argon protection, slowly add sodium borohydride (66.96g, 1.77mol) in batches, warm to room temperature and stir for 1h. After the reaction is completed, add 500ml of 1N hydrochloric acid to quench and stir for 30min, then add 3L of chloroform to extract the product. The organic phase is dried over anhydrous sodium sulfate and concentrated under reduced pressure. 240g of light yellow oil is obtained, with a yield of 99.45%.
[0065] The light yellow oil obtained above was transferred to a 5L single-mouth bottle, 1,4-dioxane (2.4L) and triphenylphosphine (231g, 0.88mol) were added, and the temperature was raised to reflux and stirred for 72h under argon protection. After the reaction was completed, the reaction solution was concentrated under reduced pressure to remove 2 / 3 of the solvent, and 2.4L of ether was added to the remaining reaction solution and stirred at room temperature for 30min. The upper clear layer was removed, and the lower viscous precipitate was concentrated under reduced pressure to obtain 375g of intermediate A methanesulfonate with a yield of 89.49%.
[0066] The NMR data of intermediate A mesylate are as follows:
[0067] 1 H NMR (400 MHz, CDCl 3 ):δ7.9-7.6(15H,m,-P + PH 3 ),3.87(6H,s,2×-OCH 3),3.6-3.5(2H,m,-CH 2 -P + PH 3 ),2.73(3H,s,-S - O 3 -CH 3 ),2.58-2.54(2H,t,J=8,ubiquinone-CH 2 -),2.13(3H,s,-CH 3 ),1.6-1.2(16H,m,(CH 2 ) 8 -).
[0068] Its H NMR spectrum is Figure 2 shown.
[0069] 2. Bromine salt of intermediate A
[0070] The bromide salt of intermediate A (hereinafter referred to as intermediate A bromide salt) is prepared from idebenone as a raw material, through the construction of OMs, bromination, reduction, and then salt formation with triphenylphosphine; the synthetic route is as follows: Figure 3 As shown, the specific synthesis method is:
[0071] Add idebenone (200g, 0.59mol), dichloromethane (3L, 15V), triethylamine (173ml, 1.24mol) to a 5L three-necked flask, cool to below 5°C in an ice-water bath, and slowly drop methyl yellow chloride (91ml, 1.18mol). After the dropwise addition, warm to room temperature and stir for 1h. Add 500ml 1N hydrochloric acid to the reaction solution and stir for 20min. Separate the liquid, extract the organic phase with 500ml water once, separate the liquid again, dry the organic phase with anhydrous sodium sulfate and concentrate under reduced pressure. Obtain 240g of a reddish brown oil with a yield of 99.53%.
[0072] Add the above-obtained red-brown oil (240 g, 0.59 mol), acetone (3 L), and lithium bromide (102.5 g, 1.18 mol) into a 5 L single-mouth bottle, heat to 60 ° C and stir for 6 h. After the reaction is completed, filter and concentrate the filtrate under reduced pressure to obtain 230 g of red-brown oil, with a yield of 97.13%.
[0073] Add the above-obtained reddish brown oil (230 g, 0.57 mol) and methanol (3.45 L) into a 10 L three-necked flask, place in an ice-water bath and cool to about 5 ° C under argon protection, slowly add sodium borohydride (64.17, 1.70 mol) in batches, warm to room temperature and stir for 1 h. After the reaction is completed, add 480 ml of 1N hydrochloric acid to quench and stir for 30 min, then add 2.9 L of chloroform to extract the product. The organic phase is dried over anhydrous sodium sulfate and concentrated under reduced pressure. 228 g of light yellow oil is obtained, with a yield of 98.63%.
[0074] The light yellow oil obtained above was transferred to a 5L single-mouth bottle, 1,4-dioxane (2.3L) and triphenylphosphine (217g, 0.83mol) were added, and the temperature was raised to reflux and stirred for 72h under argon protection. After the reaction was completed, the reaction solution was concentrated under reduced pressure to remove 2 / 3 of the solvent, and 2.3L of ether was added to the remaining reaction solution and stirred at room temperature for 30min. The upper clear layer was removed, and the lower viscous precipitate was concentrated under reduced pressure to obtain 338g of intermediate A bromide salt with a yield of 89.83%.
[0075] The NMR data of intermediate A bromide salt are as follows:
[0076] 1 H NMR (400 MHz, CDCl 3 ):δ7.9-7.6(15H,m,-P + PH 3 ),3.97,3.87(6H,s,2×-OCH 3 ),3.8-3.78(2H,m,-CH 2 -P + PH 3 ),2.57,2.41(2H,t,J=8,ubiquinone-CH 2 -), 2.12, 1.99 (3H, s, -CH 3 ),1.6-1.2(16H,m,(CH 2 ) 8 -).
[0077] Its H NMR spectrum is Figure 4 shown.
[0078] Example 1
[0079] S1. Synthesis of crude mitroquinone salt
[0080] Add the mesylate of intermediate A (260 g, 0.38 mol) to a 5L single-mouth bottle, then add ethanol (3.9 L, 15 V), stir at room temperature until intermediate A is completely dissolved, then add anhydrous ferric chloride (3.08 g, 0.019 mol), stir at room temperature for 5 hours. HPLC monitoring until the residual intermediate A is <0.1%, the reaction solution is concentrated under reduced pressure at 40-45 ° C to obtain 263 g of brown oil, i.e., crude mitroquinone salt.
[0081] S2. Purification of crude mitoquinone salt
[0082] Transfer 253g of the oil to a 2L three-necked flask, add 750ml of ethyl acetate, heat to 75°C, keep stirring for 2h, then naturally cool to room temperature 25°C. Pour off the supernatant, repeat this operation once. Finally, concentrate the precipitate under reduced pressure at 40°C to obtain 247g of brown waxy solid mitroquinone salt, with a yield of 95.28%.
[0083] Example 2
[0084] S1. Synthesis of crude mitroquinone salt
[0085] Add the bromide salt of intermediate A (250 g, 0.38 mol) to a 5 L single-mouth bottle, then add ethanol (3.9 L, 15 V), stir at room temperature until intermediate A is completely dissolved, then add anhydrous ferric chloride (6.16 g, 0.038 mol), stir at room temperature in an open state for 3 h; monitor by HPLC until the residual intermediate A is <0.1%, and obtain the crude product of mitroquinone salt.
[0086] S2. Purification of crude mitoquinone salt
[0087] Add diethylaminetetraacetic acid (11.11 g, 0.038 mol) to the product obtained in step S1, stir at room temperature for 2 h, filter, rinse the filter cake once with 200 ml of ethanol, and concentrate the filtrate under reduced pressure at 40°C to obtain 240 g of brown waxy solid mitroquinone salt, with a yield of 96.33%.
[0088] Example 3
[0089] S1. Synthesis of crude mitroquinone salt
[0090] Add the bromide salt of intermediate A (200 g, 0.30 mol) to a 5L three-necked flask, then add ethanol (3.6 L, 18 V), stir at room temperature until intermediate A is completely dissolved, then add anhydrous copper chloride (4.04 g, 0.03 mol), and stir at room temperature while passing air for 5 hours. HPLC monitoring until the residual intermediate A is <0.1%, the reaction solution is concentrated under reduced pressure at 40-45 ° C to obtain 203 g of brown oil, i.e., crude mitroquinone salt.
[0091] S2. Purification of crude mitoquinone salt
[0092] The brown oil was purified by column chromatography with 200-300 mesh silica gel and eluted with dichloromethane / methanol = 50:1. The eluate was concentrated under reduced pressure at 40° C. to obtain 182 g of brown waxy solid mitoquinone salt with a yield of 91.31%.
[0093] The HPLC data of the mitoquinone salt product obtained in Example 3 are as follows: retention time = 11.60 min, product purity > 99.8, absorption wavelength = 273 nm. Figure 5 shown.
[0094] The NMR data of the mitoquinone salt product obtained in Example 3 are as follows:
[0095] 1 H NMR (400 MHz, CDCl 3 ):δ7.9-7.6(15H,m,-P + PH 3 ),3.98(6H,s,2×-OCH 3 ),3.86-3.8(2H,m,-CH 2 -P + PH 3 ),2.41(2H,t,J=8,ubiquinone-CH 2 -),1.99(3H,s,-CH 3 ),1.6-1.2(16H,m,(CH 2 ) 8 -).
[0096] Its H NMR spectrum is Figure 6 shown.
[0097] Although the embodiments of the present invention have been disclosed as above, they are not limited to the applications listed in the specification and the implementation modes. They can be fully applied to various fields suitable for the present invention. For those familiar with the art, additional modifications can be easily implemented. Therefore, without departing from the general concept defined by the claims and the scope of equivalents, the present invention is not limited to specific details.
Claims
1. A method for preparing mitoquinone by oxidation, characterized in that: The following steps are involved: S1. The salt of intermediate A is dissolved in an organic solvent, a metal ion oxidant is added, and the mixture is stirred to react to obtain a crude product of mitroquinone salt; S2, purifying the crude product to obtain mitoquinone salt; Among them, the structural formula of intermediate A is shown as follows:
2. The method for preparing mitoquinone by oxidation according to claim 1, characterized in that: The metal ion oxidant is one or more of ferric chloride, ferric sulfate, cupric chloride and cupric bromide.
3. The method for preparing mitoquinone by oxidation according to claim 1, characterized in that: The salt of intermediate A is the mesylate of intermediate A or the bromide of intermediate A; The mesylate of intermediate A is prepared by using idebenone as a raw material, constructing OMs, reducing, and then forming a salt with triphenylphosphine. The bromide of intermediate A is prepared by using idebenone as a raw material, constructing OMs, brominating, reducing, and then forming a salt with triphenylphosphine.
4. The method for preparing mitoquinone by oxidation according to claim 3, characterized in that: The molar ratio of the salt of intermediate A to the metal ion oxidant is 1:0.01-0.
20.
5. The method for preparing mitoquinone by oxidation according to claim 1, characterized in that: The organic solvent is one or more of ethanol, methanol and dichloromethane; The volume of the organic solvent is 5 to 20 times the weight of the salt of the intermediate A, wherein the unit of volume is mL and the unit of weight is g.
6. The method for preparing mitoquinone by oxidation according to claim 1, characterized in that: The reaction time in step S1 can be 0.5-12 hours, and the reaction temperature is room temperature.
7. The method for preparing mitoquinone by oxidation according to claim 1, characterized in that: The purification process in step S2 is a combination of one or more of recrystallization, chemical precipitation, and column chromatography.
8. The method for preparing mitoquinone by oxidation according to claim 7, characterized in that: Step S2 is specifically as follows: S2-1, adding the crude product of mitoquinone salt to the recrystallization solvent, stirring at 30-120°C for 1-4h, and then cooling to 25°C; S2-2, discard the supernatant, add the product into the recrystallization solvent, stir at 30-120°C for 1-4h, then cool to 25°C, and then concentrate under reduced pressure at 40°C to obtain mitroquinone salt.
9. The method for preparing mitoquinone by oxidation according to claim 8, characterized in that: The recrystallization solvent is one or more of ethyl acetate, toluene, n-hexane and ether, and the volume of the recrystallization solvent is 1 to 10 times the weight of the crude product of mitoquinone, wherein the unit of volume is mL and the unit of weight is g.
10. The method for preparing mitoquinone by oxidation according to claim 7, characterized in that: Step S2 is specifically as follows: adding the crude product of mitoquinone salt to diethylaminetetraacetic acid, stirring at room temperature for 1-4 hours, filtering with suction, rinsing the filter cake with ethanol, and concentrating the filtrate under reduced pressure at 40° C. to obtain mitoquinone salt.
11. The method for preparing mitoquinone by oxidation according to claim 7, characterized in that: Step S2 is specifically as follows: the crude product of mitoquinone salt is purified by column chromatography with 200-300 mesh silica gel, eluted with a mixed solution of dichloromethane:methanol in a volume ratio of 50:1, and the obtained eluate is concentrated under reduced pressure at 40° C. to obtain mitoquinone salt.
Citation Information
Patent Citations
Semi-synthesis method for mitoxantrone
CN108395379A
Synthesis of triphenylphosphonium quinols and quinones
US20050043553A1
Methods for reducing anthracycline-induced toxicity
US20080032940A1
Mitoquinone Derivatives Used as Mitochondrially Targeted Antioxidants
US20080161267A1
